Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions
出版年份 2023 全文链接
标题
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions
作者
关键词
-
出版物
VASCULAR PHARMACOLOGY
Volume 152, Issue -, Pages 107212
出版商
Elsevier BV
发表日期
2023-08-22
DOI
10.1016/j.vph.2023.107212
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study
- (2023) Aris Bechlioulis et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2022) Ran Wei et al. Frontiers in Endocrinology
- Mouse aortic biomechanics are affected by short-term defective autophagy in vascular smooth muscle cells
- (2022) Dorien G. De Munck et al. Journal of Physiological Sciences
- SGLT2 inhibition attenuates arterial dysfunction and decreases vascular F-actin content and expression of proteins associated with oxidative stress in aged mice
- (2022) Rogerio N. Soares et al. GeroScience
- Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell KV7 ion channels
- (2022) Ahasanul Hasan et al. Heliyon
- Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle
- (2022) Krishna Raj Ojha et al. Frontiers in Physiology
- Progressive aortic stiffness in aging C57Bl/6 mice displays altered contractile behaviour and extracellular matrix changes
- (2022) Sofie De Moudt et al. Communications Biology
- Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration
- (2022) Jochen Dutzmann et al. Frontiers in Cardiovascular Medicine
- Sex- and age‐dependent alterations of splenic immune cell profile and NK cell phenotypes and function in C57BL/6J mice
- (2021) Kelly B. Menees et al. Immunity & Ageing
- Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling
- (2021) Yangping Shentu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK/mTOR mediated autophagy pathway
- (2021) Lei Yang et al. CELLULAR SIGNALLING
- Empagliflozin Relaxes Resistance Mesenteric Arteries by Stimulating Multiple Smooth Muscle Cell Voltage-Gated K+ (KV) Channels
- (2021) Ahasanul Hasan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High Pulsatile Load Decreases Arterial Stiffness: An ex vivo Study
- (2021) Cédric H. G. Neutel et al. Frontiers in Physiology
- Aortic Stiffness Hysteresis in Isolated Mouse Aortic Segments Is Intensified by Contractile Stimuli, Attenuated by Age, and Reversed by Elastin Degradation
- (2021) Sofie De Moudt et al. Frontiers in Physiology
- Lifelong SIRT-1 overexpression attenuates large artery stiffening with advancing age
- (2020) Daniel R. Machin et al. Aging-US
- Empagliflozin suppresses inflammation and protects against acute septic renal injury
- (2020) Zaid H. Maayah et al. INFLAMMOPHARMACOLOGY
- How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
- (2019) Agnes Bosch et al. Cardiovascular Diabetology
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minoxidil improves vascular compliance, restores cerebral blood flow, and alters extracellular matrix gene expression in a model of chronic vascular stiffness
- (2018) Russell H. Knutsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo : Role of DNA methyltransferase 1
- (2018) Si-An Xie et al. BIOMATERIALS
- Empagliflozin: A Review in Type 2 Diabetes
- (2018) James E. Frampton DRUGS
- Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
- (2018) Abdullah Kaplan et al. HEART FAILURE REVIEWS
- Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
- (2018) Annayya R. Aroor et al. Cardiovascular Diabetology
- The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
- (2018) Jyotiska Chaudhuri et al. Cell Metabolism
- Mechanisms of Vascular Aging
- (2018) Zoltan Ungvari et al. CIRCULATION RESEARCH
- Age-related changes of wall composition and collagen cross-linking in the rat carotid artery – In relation with arterial mechanics
- (2017) Kozaburo Hayashi et al. Journal of the Mechanical Behavior of Biomedical Materials
- Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators
- (2017) Christopher K. Yu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A novel set-up for theex vivoanalysis of mechanical properties of mouse aortic segments stretched at physiological pressure and frequency
- (2016) Arthur J. A. Leloup et al. JOURNAL OF PHYSIOLOGY-LONDON
- Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis
- (2015) Mandy OJ Grootaert et al. Autophagy
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Arterial structure and function in vascular ageing: are you as old as your arteries?
- (2015) Dick H. J. Thijssen et al. JOURNAL OF PHYSIOLOGY-LONDON
- The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
- (2014) David ZI Cherney et al. Cardiovascular Diabetology
- Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis
- (2013) Sayaka Maeda et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Elastin in Large Artery Stiffness and Hypertension
- (2012) Jessica E. Wagenseil et al. Journal of Cardiovascular Translational Research
- Renal glucose reabsorption inhibitors to treat diabetes
- (2011) Clifford J. Bailey TRENDS IN PHARMACOLOGICAL SCIENCES
- Aging and Arterial Stiffness
- (2010) Hae-Young Lee et al. CIRCULATION JOURNAL
- Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage
- (2008) Gary F. Mitchell JOURNAL OF APPLIED PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now